Clostridium difficile infection, a descriptive analysis of solid organ transplant recipients at a single center

Diagnostic Microbiology and Infectious Disease

Volumn 81, Issue 4, 2015, Pages 299-304

  Tsapepas, Demetra S ^a   Martin, Spencer T ^b   Miao, Jennifer ^a   Shah, Shreya A ^a   Scheffert, Jenna ^a   Fester, Keith ^a   Ma, Karlene ^a   Lat, Asma ^c   Egan, Ron ^a   McKeen, Jaclyn T ^d  

^a Department of Medicine   (United States)

^b HARTFORD HOSPITAL   (United States)

^c THERAVANCE INC   (United States)

^d HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clostridium difficile; Epidemiology; Infection; Solid organ transplantation

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; CARBAPENEM; CEPHALOSPORIN; DAPTOMYCIN; LINEZOLID; MACROLIDE; METRONIDAZOLE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; PROTON PUMP INHIBITOR; QUINOLONE DERIVATIVE; RIFAXIMIN; SULTAMICILLIN; TIGECYCLINE; VANCOMYCIN;

ACUTE GRAFT REJECTION; ADULT; AGED; ALLOGRAFT; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DISEASE COURSE; DRUG EXPOSURE; FEMALE; GRAFT RECIPIENT; HEART GRAFT; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY GRAFT; LIVER GRAFT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIORGAN TRANSPLANT; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOLID ORGAN TRANSPLANT; TIME TO INFECTION; TREATMENT DURATION; ADVERSE EFFECTS; CLOSTRIDIUM INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; SURVIVAL; TRANSPLANTATION;

ADULT; AGED; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANT RECIPIENTS; TRANSPLANTS;

EID: 84925160606     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.11.018     Document Type: Article

References (17)

1. Albright J.B., Bonatti H., Mendez J., Kramer D., Stauffer J., Hinder R., et al. Early and late onset Clostridium difficile-associated colitis following liver transplantation. Transpl Int 2007, 20(10):856-866. [Epub 2007/09/15].
2. Arslan H., Inci E.K., Azap O.K., Karakayali H., Torgay A., Haberal M. Etiologic agents of diarrhea in solid organ recipients. Transpl Infect Dis 2007, 9(4):270-275. [Epub 2007/05/22].
3. Barbut F., Richard A., Hamadi K., Chomette V., Burghoffer B., Petit J.C. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000, 38(6):2386-2388. [Epub 2000/06/02].
4. Bartlett J.G. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002, 346(5):334-339. [Epub 2002/02/01].
5. Bignardi G.E. Risk factors for Clostridium difficile infection. J Hosp Infect 1998, 40(1):1-15. [Epub 1998/10/20].
6. Boutros M., Al-Shaibi M., Chan G., Cantarovich M., Rahme E., Paraskevas S., et al. Clostridium difficile colitis: increasing incidence, risk factors, and outcomes in solid organ transplant recipients. Transplantation 2012, 93(10):1051-1057. [Epub 2012/03/24].
7. Cohen S.H., Gerding D.N., Johnson S., Kelly C.P., Loo V.G., McDonald L.C., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31(5):431-455. [Epub 2010/03/24].
8. Dubberke E.R., Burdette S.D., Practice ASTIDCo Clostridium difficile infections in solid organ transplantation. Am J Transplant 2013, 13(Suppl. 4):42-49. [Epub 2013/03/08].
9. Fishman J.A. Infection in solid-organ transplant recipients. N Engl J Med 2007, 357(25):2601-2614. [Epub 2007/12/21].
10. Jones R.N. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest 2001, 119(2 Suppl.):397S-404S. [Epub 2001/02/15].
11. Keven K., Basu A., Re L., Tan H., Marcos A., Fung J.J., et al. Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transpl Infect Dis 2004, 6(1):10-14. [Epub 2004/07/01].
12. Len O., Rodriguez-Pardo D., Gavalda J., Aguado J.M., Blanes M., Borrell N., et al. Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study. Transpl Int 2012, 25(12):1275-1281. [Epub 2012/10/09].
13. Mitu-Pretorian O.M., Forgacs B., Qumruddin A., Tavakoli A., Augustine T., Pararajasingam R. Outcomes of patients who develop symptomatic Clostridium difficile infection after solid organ transplantation. Transplant Proc 2010, 42(7):2631-2633. [Epub 2010/09/14].
14. Neofytos D., Kobayashi K., Alonso C.D., Cady-Reh J., Lepley D., Harris M., et al. Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients. Transpl Infect Dis 2013, 15(2):134-141. [Epub 2012/11/24].
15. Riddle D.J., Dubberke E.R. Clostridium difficile infection in solid organ transplant recipients. Curr Opin Organ Transplant 2008, 13(6):592-600. [Epub 2008/12/09].
16. Shah S.A., Tsapepas D.S., Kubin C.J., Martin S.T., Mohan S., Ratner L.E., et al. Risk factors associated with Clostridium difficile infection after kidney and pancreas transplantation. Transpl Infect Dis 2013, 15(5):502-509. [Epub 2013/07/31].
17. Stanley J.D., Burns R.P. Clostridium difficile and the surgeon. Am Surg 2010, 76(3):235-244. [Epub 2010/03/31].